|
|
|
|
BC00112
Multiple organ paired normal and cancer (8 types) tissue array, 48 cases/48 cores
|
|
| Microarray Panel: | Multiple organ paired normal and cancer tissue microarray, single core, 8 types of disease and normal organs (liver, colon, stomach, esophagus, intestine, pancreas, lung and epiploon) |
| Cores: | 48 |
|
| Cases: | 48 |
| Layout: | 8 cols × 6 rows |
| Core Diameter: | 1.5 mm |
| Thickness: | 5 µm | | Quality Control: | Anti-Cytokeratin (CK) confirmed | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained
paraffin
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Image |
Type † |
|
A1 |
1 |
M |
46 |
Liver |
Hepatocellular carcinoma |
I |
Image |
Malignant |
|
A2 |
2 |
M |
44 |
Colon |
Adenocarcinoma |
I |
Image |
Malignant |
|
A3 |
3 |
M |
60 |
Stomach |
Adenocarcinoma |
II |
Image |
Malignant |
|
A4 |
4 |
M |
59 |
Esophagus |
Squamous cell carcinoma |
I |
Image |
Malignant |
|
A5 |
5 |
M |
66 |
Intestine |
Adenocarcinoma |
I |
Image |
Malignant |
|
A6 |
6 |
F |
60 |
Pancreas |
Cancer adjacent tissue |
– |
Image |
Malignant |
|
A7 |
7 |
M |
46 |
Lung |
Squamous cell carcinoma |
II |
Image |
Malignant |
|
A8 |
8 |
M |
60 |
Epiploon |
Metastatic mucinous adenocarcinoma |
II |
Image |
Metastasis |
|
B1 |
9 |
M |
42 |
Liver |
Hepatocellular carcinoma |
II |
Image |
Malignant |
|
B2 |
10 |
M |
75 |
Colon |
Adenocarcinoma |
I-II |
Image |
Malignant |
|
B3 |
11 |
F |
55 |
Stomach |
Adenocarcinoma |
III |
Image |
Malignant |
|
B4 |
12 |
M |
75 |
Esophagus |
Squamous cell carcinoma |
II |
Image |
Malignant |
|
B5 |
13 |
M |
57 |
Intestine |
Adenocarcinoma |
II |
Image |
Malignant |
|
B6 |
14 |
F |
68 |
Pancreas |
Duct adenocarcinoma |
II |
Image |
Malignant |
|
B7 |
15 |
M |
57 |
Lung |
Squamous cell carcinoma |
III |
Image |
Malignant |
|
B8 |
16 |
F |
57 |
Epiploon |
Metastatic adenocarcinoma |
III |
Image |
Metastasis |
|
C1 |
17 |
M |
77 |
Liver |
Hepatocellular carcinoma |
II |
Image |
Malignant |
|
C2 |
18 |
M |
24 |
Colon |
Mucinous adenocarcinoma |
III |
Image |
Malignant |
|
C3 |
19 |
M |
74 |
Stomach |
Adenocarcinoma |
III |
Image |
Malignant |
|
C4 |
20 |
M |
58 |
Esophagus |
Squamous cell carcinoma |
II |
Image |
Malignant |
|
C5 |
21 |
F |
78 |
Intestine |
Adenocarcinoma |
III |
Image |
Malignant |
|
C6 |
22 |
F |
15 |
Pancreas |
Islet cell carcinoma |
– |
Image |
Malignant |
|
C7 |
23 |
F |
36 |
Lung |
Atypical carcinoid |
– |
Image |
Malignant |
|
C8 |
24 |
M |
52 |
Epiploon |
Metastatic adenocarcinoma |
III |
Image |
Metastasis |
|
D1 |
25 |
M |
56 |
Liver |
Cancer adjacent normal hepatic tissue |
– |
Image |
Normal |
|
D2 |
26 |
M |
49 |
Colon |
Cancer adjacent normal colonic tissue |
– |
Image |
Normal |
|
D3 |
27 |
M |
22 |
Stomach |
Cancer adjacent normal gastric tissue |
– |
Image |
Normal |
|
D4 |
28 |
F |
42 |
Esophagus |
Cancer adjacent normal esophageal tissue |
– |
Image |
Normal |
|
D5 |
29 |
M |
40 |
Intestine |
Cancer adjacent normal small intestinal tissue |
– |
Image |
Normal |
|
D6 |
30 |
F |
14 |
Pancreas |
Cancer adjacent normal pancreatic tissue |
– |
Image |
Normal |
|
D7 |
31 |
M |
40 |
Lung |
Cancer adjacent normal lung tissue |
– |
Image |
Normal |
|
D8 |
32 |
F |
55 |
Epiploon |
Cancer adjacent normal greater omentum tissue |
– |
Image |
Normal |
|
E1 |
33 |
F |
2 |
Liver |
Cancer adjacent normal hepatic tissue |
– |
Image |
Normal |
|
E2 |
34 |
M |
35 |
Colon |
Cancer adjacent normal colonic tissue |
– |
Image |
Normal |
|
E3 |
35 |
F |
50 |
Stomach |
Cancer adjacent normal gastric tissue |
– |
Image |
Normal |
|
E4 |
36 |
M |
24 |
Esophagus |
Cancer adjacent normal esophageal tissue |
– |
Image |
Normal |
|
E5 |
37 |
F |
35 |
Intestine |
Cancer adjacent normal small intestinal tissue |
– |
Image |
Normal |
|
E6 |
38 |
F |
2 |
Pancreas |
Cancer adjacent normal pancreatic tissue |
– |
Image |
Normal |
|
E7 |
39 |
M |
50 |
Lung |
Cancer adjacent normal lung tissue |
– |
Image |
Normal |
|
E8 |
40 |
F |
50 |
Epiploon |
Cancer adjacent normal greater omentum tissue |
– |
Image |
Normal |
|
F1 |
41 |
F |
50 |
Liver |
Cancer adjacent normal hepatic tissue |
– |
Image |
Normal |
|
F2 |
42 |
M |
58 |
Colon |
Cancer adjacent colonic mucosa tissue (chronic inflammation) |
– |
Image |
Normal |
|
F3 |
43 |
M |
49 |
Stomach |
Cancer adjacent normal gastric tissue |
– |
Image |
Normal |
|
F4 |
44 |
F |
21 |
Esophagus |
Cancer adjacent normal esophageal tissue |
– |
Image |
Normal |
|
F5 |
45 |
M |
49 |
Intestine |
Cancer adjacent normal small intestinal tissue |
– |
Image |
Normal |
|
F6 |
46 |
F |
35 |
Pancreas |
Cancer adjacent normal pancreatic tissue |
– |
Image |
Normal |
|
F7 |
47 |
M |
49 |
Lung |
Cancer adjacent normal lung tissue |
– |
Image |
Normal |
|
F8 |
48 |
M |
58 |
Epiploon |
Cancer adjacent normal greater omentum tissue |
– |
Image |
Normal |
† For precise diagnosis, refer to pathology description.
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
|
|